PolyMedica Explains Medicare Over-Billing, Accrues Reserves For Repayment
This article was originally published in The Gray Sheet
Executive Summary
PolyMedica will seek growth through acquisitions to offset an average 3% reduction in reimbursement rates for its diabetes products that will become effective in 2005 under the recent Medicare law